hit counter

Antidepressants Did Not Shift Facial Emotion Recognition in Depression

MHD featured image for antidepressant maintenance and facial emotion recognition in recurrent depression.

A 2026 ANTLER mechanistic analysis found no evidence that maintaining antidepressants preserved a happier facial-emotion recognition pattern compared with placebo substitution at 12 weeks (adjusted mean difference 0.23, 95% CI −0.5 to 1.0, p = 0.5) or 52 weeks (0.29, 95% CI −0.5 to 1.2, p = 0.5). Research Highlights No 12-week maintenance advantage: discontinuation …

Read more

Social Anxiety: Prefrontal Connectivity Differs but Amygdala-PFC Doesn’t

Stylized fMRI connectivity map showing prefrontal and amygdala circuits during emotion regulation in social anxiety disorder.

The textbook story of social anxiety disorder is broken amygdala-prefrontal regulation — an overactive threat system the prefrontal cortex can’t calm down. A 2026 effective-connectivity study of 102 adults found something different: amygdala-prefrontal connectivity didn’t differ between social anxiety patients and controls, but connectivity between prefrontal regions did, particularly involving the pre-supplementary motor area.1 Research …

Read more

Postpartum Depression Brain Activity: 12-Study fMRI Meta-Analysis

Stylized resting-state brain scan with highlighted amygdala, precuneus, and neurotransmitter systems, representing fMRI meta-analysis findings in postpartum depression.

Resting-state fMRI studies of postpartum depression have produced inconsistent results for years. A 2026 voxel-based meta-analysis pooled 12 studies of 475 patients and found 4 reliable regional differences (amygdala, precuneus, occipital, precentral cortex) at uncorrected thresholds, none of which held up under strict family-wise error correction.1 Research Highlights 12-study fMRI pool: Chen et al. analyzed …

Read more

Antidepressant Use in Pakistan (2026): SSRI Prescribing Patterns and Patient-Reported Side Effects

Photoreal illustration of a pharmacist counseling patient on antidepressant medication, conveying global pharmacovigilance.

Most antidepressant pharmacovigilance data come from high-income countries, leaving prescribing patterns and adverse-effect profiles in low- and middle-income countries underdocumented. A 2026 cross-sectional study by Riaz and colleagues describes antidepressant use in Pakistan, with patient-reported adverse effects mapped against prescription patterns.1 Research Highlights Antidepressant use in low- and middle-income countries (LMICs) has grown substantially but …

Read more

SSRIs + DOACs: No Excess Bleeding vs. Other Antidepressants

Stylized illustration of an SSRI capsule alongside a DOAC tablet against a vascular network background, representing the bleeding-interaction question in primary care.

SSRIs raise bleeding risk on their own. DOACs (direct oral anticoagulants — apixaban, rivaroxaban, dabigatran, edoxaban) raise it more. The intuitive worry is that combining them stacks the two effects. A new BJGP Open analysis from Chau and colleagues argues the stacking is smaller than most popular framings claim, and that the real safety question …

Read more

Maternal Health and Autism Risk: Most Links Are Genetic, Not Prenatal

Stylized illustration of a multi-generation family tree branching into cousin pairs, representing the 3-generation registry design used to separate inherited from in-utero genetic effects on autism risk.

For two decades, headlines have linked autism to maternal obesity, depression, anxiety, gestational diabetes, infection, autoimmune disease, and antidepressant use. The studies behind those headlines are well-replicated registry associations. A new design from the Aarhus University iPSYCH group offers the most careful answer yet to what they mean for an individual pregnancy. Most “maternal X …

Read more

SSRI-Induced Sexual Dysfunction Reversed with “Drug Holidays” on Weekends (2024 Study)

Selective serotonin reuptake inhibitors (SSRIs) are a mainstay in the treatment of various mental disorders but often come with the unwelcome side effect of sexual dysfunction. This issue can significantly affect patients’ adherence to their medication regime, often leading to treatment discontinuation. A recent clinical trial offers a new perspective, suggesting that ‘drug holidays’ – …

Read more